NCT05800210View on ClinicalTrials.gov

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaJuvenile Myelomonocytic LeukemiaMyelodysplastic SyndromesChronic Myeloid LeukemiaLymphoma, Non-HodgkinLymphoma, Hodgkin
Interventions
DEVICE

Miltenyi CliniMACS Prodigy ® system

Subjects will receive an allogeneic stem cell transplant that has been depleted of ⍺/β CD3+ T-cells and CD19+ B-cells using the Miltenyi CliniMACS Prodigy® system.

Trial Locations (1)

32608

RECRUITING

University of Florida, Gainesville

All Listed Sponsors
collaborator

Florida Department of Health

OTHER_GOV

collaborator

Ocala Royal Dames for Cancer Research

UNKNOWN

lead

University of Florida

OTHER